DEXCOM INC
SAN DIEGO, CA · CIK 0001093557 · Medtech · Public
Continuous glucose monitoring device that measures blood glucose in real-time via a wearable sensor
dexcom.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $11M
- 2 Form D · May 2016
- 125 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 18 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201120122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,964,019 | |
| Private capital raised | Form D · SEC | $7,225,664 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1037 | Stratosphere ATC LLC | — | $250K |
| 1038 | Coagulation Sciences LLC | — | $2.1M |
| 1039 | Prana Interactive Inc. | — | $328K |
| 1040 | DEXCOM INC | — | $11M |
| 1041 | Aquillius Corporation | — | — |
| 1042 | BIOMEDICA MANAGEMENT CORPORATION | — | $300K |
| 1043 | Lazurite Inc. | — | $9.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steven AltmanDirector
- Nicholas AugustinosDirector
- Andrew BaloExecutive Officer
- Martin DoordanDirector
- Richard DoubledayExecutive Officer
- Mark FolettaDirector
- Terrance GreggDirector · Executive Officer
- Barbara KahnDirector
- John ListerExecutive Officer
- Jonathan LordDirector
- Jeffrey MoyExecutive Officer
- Steven PacelliExecutive Officer
- Jess RoperExecutive Officer
- Kevin SayerDirector · Executive Officer
- Jay SkylerDirector
- Eric TopolDirector
- Jorge ValdesExecutive Officer
Patents
- Systems And Methods For Activating A Circuit Of An Implant Deviceapplication
- Dynamic Equivalent On Board Estimatorapplication
- Sensor Interposer Employing Castellated Through-viasapplication
- Systems And Methods For Enhanced Wireless Communications Between Analyte Sensor Systems And Display Devicesapplication
- Tracking, Reporting, And Visualizing Pregnancy-related Analyte Datagranted
- System And Method For Mode Switchinggranted
- Use Of Sensor Redundancy To Detect Sensor Failuresapplication
- Applicators For Applying Transcutaneous Analyte Sensors And Associated Methods Of Manufactureapplication
- Devices And Methods For Measuring A Concentration Of A Target Analyte In A Biological Fluid In Vivogranted
- Therapeutic Zone Assessorapplication
- Private Synthetic Time Series Data Generationgranted
- Systems And Methods For Dynamically And Intelligently Monitoring A Host's Glycemic Condition After An Alert Is Triggeredgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.